Artelo Biosciences, Inc. (ARTL) Misses Q2 EPS by 548c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q2 EPS of ($5.61), $5.48 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Active options: MSFT WULF PLTR NOK AMD GOOGL IBM META CMG SMCI HOOD AVGO
• DoE Announces Conditional $17.5B Financing to Support Westinghouse Nuclear Reactor Deployment